IP Library Granted Patent US 7,642,300
Granted Patent B2
US 7,642,300 · App. 10/562,591 · Granted Jan 5, 2010

Hydroxyapatite grafted fumarate based macromers for biodegradable composites

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,642,300
App. No.
10/562,591
Granted
Jan 5, 2010
Kind
B2
Abstract

A composition is disclosed which comprises (i) a macromer prepared by reacting an unsaturated diacid having a carbon-carbon double bond and a saturated diacid, and (ii) a bioactive ceramic grafted to the macromer. In one embodiment, the unsaturated diacid having a carbon-carbon double bond is fumaric acid, the saturated diacid is compatible with fumaric acid and poly(propylene fumarate) such as succinic acid, glutaric acid, adipic acid, pimelic acid, suberic acid, azelaic acid, sebacic acid and mixtures thereof, and the bioactive ceramic is hydroxyapatite. In another embodiment, hydroxyapatite is grafted with a biodegradable and crosslinkable macromer comprising silane units alternating with furnarate and adipate units.

Claims (53)

1. A composition comprising:

a macromer prepared by reacting an unsaturated diacid having a carbon-carbon double bond and a saturated diacid, wherein the unsaturated diacid having a carbon-carbon double bond is fumaric acid; and

a bioactive ceramic grafted to the macromer, wherein the bioactive ceramic is hydroxyapatite grafted to the macromer by way of silicate groups.

2. A biodegradable composite comprising:

(a) a polymeric matrix; and

(b) the composition of claim 1 crosslinked to the matrix.

3. The composite of claim 2 wherein:

the matrix has a carbon-carbon double bond.

4. The composite of claim 3 wherein:

the matrix comprises poly(propylene fumarate).

5. The composite of claim 2 wherein:

the composite is suitable as a scaffold for tissue regeneration.

6. The composite of claim 5 wherein:

the tissue is bone.

7. A crosslinkable, biodegradable material comprising:

a polymer having a carbon-carbon double bond;

the composition of claim 1 , and

a crosslinking agent for crosslinking the polymer and the composition.

8. The material of claim 7 wherein:

the polymer comprises poly(propylene fumarate).

9. The material of claim 8 wherein:

the crosslinking agent is a free radical initiator.

10. The composition of claim 1 wherein:

the saturated diacid is selected from diacids compatible with fumaric acid and poly(propylene fumarate).

11. The composition of claim 10 wherein:

the saturated diacid is selected from succinic acid, glutaric acid, adipic acid, pimelic acid, suberic acid, azelaic acid, sebacic acid and mixtures thereof.

12. A composition comprising:

a macromer prepared by reacting an unsaturated diacid having a carbon-carbon double bond, a saturated diacid and a silane coupling agent; and

a bioactive ceramic grafted to the macromer.

13. The composition of claim 12 wherein:

the unsaturated diacid having a carbon-carbon double bond is fumaric acid, the saturated diacid is selected from diacids compatible with fumaric acid and poly(propylene fumarate), and the silane coupling agent is a dihalodialkylsilane.

14. The composition of claim 13 wherein:

the saturated diacid is selected from succinic acid, glutaric acid, adipic acid, pimelic acid, suberic acid, azelaic acid, sebacic acid and mixtures thereof.

15. The composition of claim 12 wherein:

the macromer is prepared by reacting the unsaturated diacid having a carbon-carbon double bond, the saturated diacid, the silane coupling agent, and an ester of the saturated diacid.

16. The composition of claim 15 wherein:

the saturated diacid is adipic acid,

the silane coupling agent is a dichlorodimethylsilane, and

the ester is a monomethyl ester of adipic acid.

17. The composition of claim 15 wherein:

the bioactive ceramic comprises hydroxyapatite particles having a particle size of less than 10,000 nanometers.

18. A composition comprising:

a macromer including silane units, units derived from an unsaturated diacid having a carbon-carbon double bond, and units derived from a saturated diacid; and

a bioactive ceramic grafted to the macromer.

19. The composition of claim 18 wherein:

the macromer includes silane units, fumarate units, and units derived from a saturated diacid, and

the bioactive ceramic is hydroxyapatite.

20. The composition of claim 18 wherein:

the macromer includes silane units, fumarate units, and adipate units, and the bioactive ceramic is hydroxyapatite.

21. The composition of claim 18 wherein:

the bioactive ceramic is hydroxyapatite.

22. The composition of claim 21 wherein:

the hydroxyapatite is grafted to the macromer by way of silicate groups.

Assignments (2)
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Sep 8, 2008
From: MAYO FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021493/0537 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2006
From: YASZEMSKI, MICHAEL J.; CURRIER, BRADFORD L.; JABBARI, ESMAIEL; LU, LICHUN
To: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
Reel/Frame 017779/0034 →
Continuity (2)
Provisional Application 6048421500 · Jul 1, 2003
Related Publication 20060241246A1 · Oct 26, 2006